Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Youwen FangPaul Dent

Abstract

Previous studies have demonstrated in hepatocytes that deoxycholic acid (DCA) promotes inactivation of protein tyrosine phosphatases (PTPases) and activation of ERBB1 and the extracellular-regulated kinase (ERK) 1/2 pathway. The present studies have determined the biochemical mechanism(s) through which these events occur. DCA and taurodeoxycholic acid (TDCA) (100 micromol/L) caused activation of ERBB1, insulin receptor, and the ERK1/2 and AKT pathways in primary rodent hepatocytes. DCA- and TDCA-induced receptor and signaling pathway activations were blocked by the reactive oxygen species (ROS) scavengers N-acetyl cysteine (NAC) and Trolox (TX), as well as by cyclosporin A (CsA) and bongkrekic acid (BKA). DCA activated the ERK1/2 pathway in HuH7 human hepatoma cells that was blocked by the incubation of cells with an ERBB1 inhibitor, NAC, TX, CsA, or BKA. DCA did not activate the ERK1/2 pathway in mitochondria-defective HuH7 Rho 0 cells. In HuH7 cells and primary hepatocytes, DCA enhanced the production of ROS, an effect that was abolished in Rho 0 cells and by prior incubation of cells with CsA or BKA. In hepatocytes and HuH7 cells, DCA inhibited PTPase activity. Incubation of hepatocytes with either CsA or BKA prevented DCA-i...Continue Reading

Citations

Mar 6, 2013·Applied Biochemistry and Biotechnology·Wei SongQing-Xi Chen
Mar 9, 2005·Biochemical and Biophysical Research Communications·D Stroup, J R Ramsaran
Oct 26, 2005·Biochemical Society Transactions·J W ZmijewskiV M Darley-Usmar
Mar 25, 2006·The Journal of Clinical Investigation·Ke MaDavid D Moore
Sep 18, 2010·Journal of Lipid Research·Valentina VolynetsIna Bergheim
Apr 7, 2009·Journal of Lipid Research·John Y L Chiang
Jan 1, 2008·Clinical and Experimental Gastroenterology·Claire M PayneHarris Bernstein
Jul 17, 2014·Digestive Diseases and Sciences·Sara M Centuori, Jesse D Martinez
Dec 27, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bryan L Copple, Tiangang Li
Sep 10, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Nathalie Zucchini-PascalRoger Rahmani
May 20, 2015·Archives of Toxicology·Richard D BegerLaura P James
Jul 15, 2016·Archives of Toxicology·María Teresa Luján PinoSandra Viviana Verstraeten
Jan 27, 2006·The Journal of Pharmacology and Experimental Therapeutics·Michael SaborowskiJyrki J Eloranta
Oct 25, 2014·The Journal of Biological Chemistry·Tianzheng YuYisang Yoon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.